Achalasia was initially attributed to myotonia of the lower esophagial sphincter (LES) (1) . The authors should clarify if the patient also had myotonia of the skeletal muscles when achalasia was first diagnosed. The authors should clarify if the patient was treated with mexiletine for myotonia of the LES, which has an anti-myotonic effect, and if mexiletine was beneficial for myotonic achalasia.
Since the outcome of MD1/MD2 strongly depends on the degree of cardiac involvement, The authors should clarify if the index patient had AV-blocks, ventricular arrhythmias, hypertrophic cardiomyopathy, dilated cardiomyopathy, or noncompaction. It should be mentioned if achalasia affected the vagal nerve and consequently the heart rhythm and propensity for developing arrhythmias.
Overall, this interesting article could be more meaningful if the points outlined above were addressed. We require detailed descriptions of exceptional cases of myotonic dystrophy.
